Five highlights from FDA’s new AI device regulation Action Plan
By EsqSocial Corporation 15/01/21
On January 12, the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) Digital Health Center of Excellence released its new five-part “Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan,”......
By: Hogan Lovells